1. Oral ciclopirox olamine displays biological activity in a phase I study in patients with advanced hematologic malignancies. Issue 4 (3rd March 2014) Authors: Minden, Mark D.; Hogge, Donna E.; Weir, Scott J.; Kasper, Jim; Webster, Debra A.; Patton, Lavonne; Jitkova, Yulia; Hurren, Rose; Gronda, Marcela; Goard, Carolyn A.; Rajewski, Lian G.; Haslam, John L.; Heppert, Kathleen E.; Schorno, Kevin; Chang, Hong; Brandwein, Joseph M.; Gupta, Vikas; Schuh, An... Journal: American journal of hematology Issue: Volume 89:Issue 4(2014:Apr.) Page Start: 363 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗